Vertex Pharmaceuticals (VRTX) Debt to Equity (2009 - 2016)
Vertex Pharmaceuticals' quarterly Debt to Equity came in at $0.22 in Q4 2016, down 16.94% year-on-year from $0.27 in Q1 2016, and down 9.02% quarter-over-quarter from $0.25 in Q3 2016.
Vertex Pharmaceuticals has reported Debt to Equity for 6 years, with the latest figure at $0.22 in Q4 2016.
- For the quarter ending Q4 2016, Debt to Equity fell 16.94% year-over-year to $0.22; the trailing twelve-month figure through Dec 2016 stood at $0.22 (down 16.94% YoY), and the FY2016 full-year result was $0.22, down 16.94% from the prior year.
- Debt to Equity for Q4 2016 stood at $0.22, down from $0.25 in the prior quarter.
- The five-year high for Debt to Equity was $0.3 in Q1 2015, with the low at $0.22 in Q4 2016.
- Average Debt to Equity over 3 years is $0.26, with a median of $0.27 recorded in 2014.
- Year-over-year, Debt to Equity rose 7.39% in 2015 and fell 16.94% in 2016.
- Tracing VRTX's Debt to Equity over 3 years: stood at $0.27 in 2014, then grew by 0.36% to $0.27 in 2015, then fell by 16.94% to $0.22 in 2016.
- The last three Debt to Equity figures came in at $0.22 (Q4 2016), $0.25 (Q3 2016), and $0.25 (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 0.22 |
| Sep 30, 2016 | 0.25 |
| Jun 30, 2016 | 0.25 |
| Mar 31, 2016 | 0.27 |
| Dec 31, 2015 | 0.27 |
| Sep 30, 2015 | 0.27 |
| Jun 30, 2015 | 0.28 |
| Mar 31, 2015 | 0.30 |
| Dec 31, 2014 | 0.27 |
| Sep 30, 2014 | 0.25 |
| Sep 30, 2011 | 0.14 |
| Mar 31, 2011 | 0.24 |
| Dec 31, 2010 | 0.15 |
| Sep 30, 2010 | 0.07 |
| Jun 30, 2010 | 0.20 |
| Dec 31, 2009 | 0.13 |